Active surveillance and response evaluation strategy after neoadjuvant therapy for esophageal cancer / 中华放射肿瘤学杂志
Chinese Journal of Radiation Oncology
;
(6): 848-853, 2022.
Artículo
en Chino
| WPRIM
| ID: wpr-956923
ABSTRACT
A considerable proportion of esophageal carcinoma patients could achieve pathological complete response (pCR) after neoadjuvant therapy, for whom accurate response evaluation and active surveillance rather than surgery-aiming to avoid the complications, mortality and reduced quality of life after surgery-has become a research hotspot. To detect residual disease and predict pCR accurately by appropriate method(s) is the key of active surveillance strategy. In this article, we elaborated the active surveillance strategy of esophageal cancer and characteristics of different evaluation methods in terms of radiology, pathology and combined detection.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Chinese Journal of Radiation Oncology
Año:
2022
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS